ホーム>>4-Hydroxyestradiol

4-Hydroxyestradiol (Synonyms: 4-Hydroxy-17β-estradiol)

カタログ番号GC19552

4-ヒドロキシエストラジオール (4-ヒドロキシ-17β-エストラジオール) は、エストラジオールの内因性代謝産物です。 4-ヒドロキシエストラジオールは発がん性があり、乳房上皮細胞で変異原性を示します。 4-ヒドロキシエストラジオールは、0.48 nM の Ki で、競合的にエストラジオールのエストロゲン受容体への結合を阻害します。

Products are for research use only. Not for human use. We do not sell to patients.

4-Hydroxyestradiol  化学構造

Cas No.: 5976-61-4

サイズ 価格 在庫数 個数
500µg
$79.00
在庫あり
1mg
$149.00
在庫あり
5mg
$465.00
在庫あり
10mg
$849.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 2 publications

Description Chemical Properties Product Documents Related Products

4-Hydroxyestradiol is a catechol estrogen and minor metabolite of estrogen.[1][2] 4-Hydroxyestradiol is formed from estrogen by the cytochrome P450 (CYP) isoform CYP1B1.[2]  Production of 4-hydroxyestradiol is increased in microsomes prepared from human mammary adenocarcinoma and fibroadenoma microsomes compared with microsomes prepared from non-cancerous tissues.[1] 4-Hydroxyestradiol (25 mg/animal) induces renal tumor formation in male hamsters.[3]

Reference:
[1]. Liehr, J.C., and Ricci, M.J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA 93(8), 3294-3296 (1996).
[2]. Yager, J.D., and Liehr, J.G. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 36, 203-232 (1996).
[3]. Liehr, J.G., Fang, W.F., Sirbasku, D.A., et al. Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem. 24(1), 353-356 (1986).

レビュー

Review for 4-Hydroxyestradiol

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 4-Hydroxyestradiol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.